You act as a paraphrase tool. Your role involves understanding the provided text…
- User
System: You act as a paraphrase tool. Your role involves understanding the provided text and then providing a positive example that keeps the original meaning of the text unchanged while using synonyms, interchanging, adding or removing words or sentences, and then provide a negative example where the meaning of the original text is at its opposite. Output your response with the following format : Positive : Negative :
User: Government authorities in the United States, at the federal, state and local level, and in other countries, extensively regulate, among other things, the research, development, testing, manufacture, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, import and export of pharmaceutical products such as those we are developing. The processes for obtaining regulatory approvals in the United States and in foreign countries, along with subsequent compliance with applicable statutes and regulations, require the expenditure of substantial time and financial resources. A failure to comply with such laws and regulations or prevail in any enforcement action or litigation related to noncompliance could have a material adverse impact on our business, financial condition and results of operations and could cause the market value of our shares to decline. Some of the product candidates we are developing, including SBI-100, will be subject to U.S. controlled substance laws and regulations, and failure to comply with or the cost of compliance with these laws and regulations, may adversely affect the results of our business operations, and our financial condition. Some product candidates we plan to develop will contain controlled substances as defined in the CSA. Controlled substances that are pharmaceutical products are subject to a high degree of regulation under the CSA, which establishes, among other things, certain registration, manufacturing quotas, security, recordkeeping, reporting, import, export and other requirements administered by the DEA. The DEA classifies Assistant:
- Assistant
Positive: U.S. government authorities, as well as those in other nations, rigorously oversee various aspects such as the research, development, testing, production, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, importation, and exportation of pharmaceutical products like the ones we are working on. The procedure to acquire regulatory approvals both in the United States and internationally, followed by compliance with applicable laws and regulations, demands a significant investment of time and financial resources. Noncompliance with these laws and regulations or losing any enforcement action or legal dispute related to noncompliance could severely impact our business, financial stability, and operational results, possibly reducing the market value of our shares. Some of our product candidates, including SBI-100, will be governed by U.S. controlled substance laws, and noncompliance or the expense associated with compliance with these laws could negatively impact our business operations and financial status. Certain product candidates we intend to develop will include substances regulated under the CSA, which imposes thorough regulation, such as registration, manufacturing quotas, security, recordkeeping, reporting, import, export, and other requirements overseen by the DEA.
Negative: In the United States and other countries, government authorities do not regulate the research, development, testing, manufacture, packaging, storage, recordkeeping, labeling, advertising, promotion, distribution, marketing, import, and export of pharmaceutical products. Obtaining regulatory approvals is quick and inexpensive, with little need for time or financial resources. Even noncompliance with such regulations tends not to impact our business, financial condition, or operations negatively. There is little to no regulatory oversight on controlled substances, and compliance costs are minimal. The DEA does not impose strict governance or requirements on pharmaceuticals classified as controlled substances.